Head to head
S&P Global vs CME Group
Side-by-side on the measures that matter, with a plain-English read. Full detail: SPGI · CME
SPGI
S&P Global
405.32+0.30%
1-year price shape — -15% over the period
Quant Rating E · 10/100
vs
CME
CME Group
276.01+1.79%
1-year price shape — +10% over the period
Quant Rating C · 38/100
CME Group edges it on the scoreable measures. CME Group has the highest Quant Rating (38); CME Group has done best over the past year (+10%); CME Group trades cheapest on trailing earnings.
| SPGI | CME | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Financial Data & Stock Exchanges |
| Last price | 405.32 | 276.01 |
| Change today | +0.30% | +1.79% |
| 1-year return | -14.9% | +10.0% |
| Market cap | $119.49B | $99.25B |
| 52-week range | 358.47 – 518.76 | 217.29 – 318.32 |
| Valuation | ||
| P/E (TTM) | 24.67 | 23.41 |
| P/E percentile, own 5-yr range | 5th | 12th |
| P/B | 3.79 | 3.74 |
| Dividend yield | 0.95% | 4.08% |
| Profitability & growth | ||
| EPS (TTM) | 14.66 | 11.16 |
| Net profit (TTM) | $4.32B | $4.01B |
| Revenue (TTM) | $16.12B | $6.77B |
| Revenue growth (YoY) | +10.4% | +0.8% |
| Gross margin | 70.9% | 86.2% |
| Operating margin | 41.6% | 65.1% |
| Net margin | 30.5% | 63.0% |
| Free cash flow (TTM) | $5.57B | $4.21B |
| Ownership & sentiment | ||
| Institutional ownership | 89.8% | 92.0% |
| Insider activity (12mo) | 5 buy / 2 sell | 18 buy / 4 sell |
| Short interest (% of float) | 2.4% | 1.6% |
| Analyst consensus | 100% buy (17) | 40% buy / 40% hold / 20% sell (10) |
| Analyst price target | $523 (+29%) | $279 (+1%) |
| StockVane view | ||
| StockVane Quant Rating | E (10) | C (38) |
| Company | ||
| Employees | 44,500 | 3,875 |
| Founded | 1917 | 1898 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.